Prestige Consumer Healthcare Sees FY25 Revenue Growth ~1%, EPS $4.40-$4.46 vs $4.62 Est.
Portfolio Pulse from Benzinga Newsdesk
Prestige Consumer Healthcare projects its FY25 revenue growth to be around 1%, with an EPS range of $4.40-$4.46, which is below the estimated $4.62.
May 14, 2024 | 9:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Prestige Consumer Healthcare's FY25 revenue and EPS projections are below expectations, indicating potential pressure on stock price.
The company's forecasted revenue growth and EPS for FY25 are below analyst estimates, which could lead to negative investor sentiment and potentially lower stock prices in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100